255 related articles for article (PubMed ID: 16191191)
21. Human Speedy: a novel cell cycle regulator that enhances proliferation through activation of Cdk2.
Porter LA; Dellinger RW; Tynan JA; Barnes EA; Kong M; Lenormand JL; Donoghue DJ
J Cell Biol; 2002 Apr; 157(3):357-66. PubMed ID: 11980914
[TBL] [Abstract][Full Text] [Related]
22. Formation of p27-CDK complexes during the human mitotic cell cycle.
Soos TJ; Kiyokawa H; Yan JS; Rubin MS; Giordano A; DeBlasio A; Bottega S; Wong B; Mendelsohn J; Koff A
Cell Growth Differ; 1996 Feb; 7(2):135-46. PubMed ID: 8822197
[TBL] [Abstract][Full Text] [Related]
23. Meiotic regulation of the CDK activator RINGO/Speedy by ubiquitin-proteasome-mediated processing and degradation.
Gutierrez GJ; Vögtlin A; Castro A; Ferby I; Salvagiotto G; Ronai Z; Lorca T; Nebreda AR
Nat Cell Biol; 2006 Oct; 8(10):1084-94. PubMed ID: 16964245
[TBL] [Abstract][Full Text] [Related]
24. Speedy A-Cdk2 binding mediates initial telomere-nuclear envelope attachment during meiotic prophase I independent of Cdk2 activation.
Tu Z; Bayazit MB; Liu H; Zhang J; Busayavalasa K; Risal S; Shao J; Satyanarayana A; Coppola V; Tessarollo L; Singh M; Zheng C; Han C; Chen Z; Kaldis P; Gustafsson JÅ; Liu K
Proc Natl Acad Sci U S A; 2017 Jan; 114(3):592-597. PubMed ID: 28031483
[TBL] [Abstract][Full Text] [Related]
25. Studies on the in vitro phosphorylation of HSSB-p34 and -p107 by cyclin-dependent kinases. Cyclin-substrate interactions dictate the efficiency of phosphorylation.
Gibbs E; Pan ZQ; Niu H; Hurwitz J
J Biol Chem; 1996 Sep; 271(37):22847-54. PubMed ID: 8798463
[TBL] [Abstract][Full Text] [Related]
26. Structural prediction of the interaction of the tumor suppressor p27
Li J; Vervoorts J; Carloni P; Rossetti G; Lüscher B
BMC Bioinformatics; 2017 Jan; 18(1):15. PubMed ID: 28056778
[TBL] [Abstract][Full Text] [Related]
27. Cyclin D2 activates Cdk2 in preference to Cdk4 in human breast epithelial cells.
Sweeney KJ; Sarcevic B; Sutherland RL; Musgrove EA
Oncogene; 1997 Mar; 14(11):1329-40. PubMed ID: 9178893
[TBL] [Abstract][Full Text] [Related]
28. Distinct properties of cyclin-dependent kinase complexes containing cyclin A1 and cyclin A2.
Joshi AR; Jobanputra V; Lele KM; Wolgemuth DJ
Biochem Biophys Res Commun; 2009 Jan; 378(3):595-9. PubMed ID: 19056339
[TBL] [Abstract][Full Text] [Related]
29. Autocatalytic phosphorylation of CDK2 at the activating Thr160.
Abbas T; Jha S; Sherman NE; Dutta A
Cell Cycle; 2007 Apr; 6(7):843-52. PubMed ID: 17361108
[TBL] [Abstract][Full Text] [Related]
30. Cytoplasmic displacement of cyclin E-cdk2 inhibitors p21Cip1 and p27Kip1 in anchorage-independent cells.
Orend G; Hunter T; Ruoslahti E
Oncogene; 1998 May; 16(20):2575-83. PubMed ID: 9632134
[TBL] [Abstract][Full Text] [Related]
31. The cell-cycle regulated transcription factor B-Myb is phosphorylated by cyclin A/Cdk2 at sites that enhance its transactivation properties.
Saville MK; Watson RJ
Oncogene; 1998 Nov; 17(21):2679-89. PubMed ID: 9840932
[TBL] [Abstract][Full Text] [Related]
32. Specificity of natural and artificial substrates for human Cdc25A.
Rudolph J; Epstein DM; Parker L; Eckstein J
Anal Biochem; 2001 Feb; 289(1):43-51. PubMed ID: 11161293
[TBL] [Abstract][Full Text] [Related]
33. The cyclin-dependent kinase (CDK) family member PNQALRE/CCRK supports cell proliferation but has no intrinsic CDK-activating kinase (CAK) activity.
Wohlbold L; Larochelle S; Liao JC; Livshits G; Singer J; Shokat KM; Fisher RP
Cell Cycle; 2006 Mar; 5(5):546-54. PubMed ID: 16552187
[TBL] [Abstract][Full Text] [Related]
34. Constitutively active K-cyclin/cdk6 kinase in Kaposi sarcoma-associated herpesvirus-infected cells.
Van Dross R; Yao S; Asad S; Westlake G; Mays DJ; Barquero L; Duell S; Pietenpol JA; Browning PJ
J Natl Cancer Inst; 2005 May; 97(9):656-66. PubMed ID: 15870436
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity.
Coppock DL; Buffolino P; Kopman C; Nathanson L
Exp Cell Res; 1995 Nov; 221(1):92-102. PubMed ID: 7589260
[TBL] [Abstract][Full Text] [Related]
36. G1 phase accumulation induced by UCN-01 is associated with dephosphorylation of Rb and CDK2 proteins as well as induction of CDK inhibitor p21/Cip1/WAF1/Sdi1 in p53-mutated human epidermoid carcinoma A431 cells.
Akiyama T; Yoshida T; Tsujita T; Shimizu M; Mizukami T; Okabe M; Akinaga S
Cancer Res; 1997 Apr; 57(8):1495-501. PubMed ID: 9108451
[TBL] [Abstract][Full Text] [Related]
37. p21 contains independent binding sites for cyclin and cdk2: both sites are required to inhibit cdk2 kinase activity.
Fotedar R; Fitzgerald P; Rousselle T; Cannella D; Dorée M; Messier H; Fotedar A
Oncogene; 1996 May; 12(10):2155-64. PubMed ID: 8668341
[TBL] [Abstract][Full Text] [Related]
38. Distinct activation pathways confer cyclin-binding specificity on Cdk1 and Cdk2 in human cells.
Merrick KA; Larochelle S; Zhang C; Allen JJ; Shokat KM; Fisher RP
Mol Cell; 2008 Dec; 32(5):662-72. PubMed ID: 19061641
[TBL] [Abstract][Full Text] [Related]
39. Speedy/RINGO regulation of CDKs in cell cycle, checkpoint activation and apoptosis.
Gastwirt RF; McAndrew CW; Donoghue DJ
Cell Cycle; 2007 May; 6(10):1188-93. PubMed ID: 17507798
[TBL] [Abstract][Full Text] [Related]
40. Identification of CDK2 substrates in human cell lysates.
Chi Y; Welcker M; Hizli AA; Posakony JJ; Aebersold R; Clurman BE
Genome Biol; 2008 Oct; 9(10):R149. PubMed ID: 18847512
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
